NFKB1 and neoplasm: In fact, the lack of CYLD function has been detected in many human tumor cells of lung, stomach and breast cancer, in which the activation of NF-κB, JNK and/or c-Myc appears as the mechanisms through which CYLD downregulation promotes tumor development [10–12].